Literature DB >> 16391491

A Spanish founder mutation in the chloride channel gene, CLCNKB, as a cause of atypical Bartter syndrome in adult age.

Juan José Gorgojo1, Sergio Donnay, Nikola Jeck, Martin Konrad.   

Abstract

BACKGROUND: Mutations in the chloride channel gene, CLCNKB, usually cause classic Bartter syndrome (cBS) or a mixed Bartter-Gitelman phenotype in the first years of life.
METHODS: We report an adult woman with atypical BS caused by a homozygous missense mutation, A204T, in the CLCNKB gene, which has previously been described as the apparently unique cause of cBS in Spain.
RESULTS: The evaluation of this patient revealed an overlap of phenotypic features ranging from severe biochemical and systemic disturbances typical of cBS to scarce symptoms and diagnosis in the adult age typical of Gitelman syndrome. The tubular disease caused a dramatic effect on mental, growth and puberal development leading to low IQ, final short stature and abnormal ovarian function. Furthermore, low serum PTH concentrations with concomitant nephrocalcinosis and normocalcaemia were observed. Both ovarian function and serum PTH levels were normalized after treatment with cyclooxygenase inhibitors.
CONCLUSIONS: The present report confirms a weak genotype-phenotype correlation in patients with CLCNKB mutations and supports the founder effect of the A204T mutation in Spain. In our country, the genetic diagnosis of adult patients with hereditary hypokalaemic tubulopathies should include a screening of A204T mutation in the CLCNKB gene. Copyright 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391491     DOI: 10.1159/000090601

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  7 in total

1.  Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations.

Authors:  Amar Al Shibli; Hassib Narchi
Journal:  World J Methodol       Date:  2015-06-26

2.  Gitelman syndrome due to p.A204T mutation in CLCNKB gene.

Authors:  R Enríquez; V Adam; A E Sirvent; A B García-García; I Millán; F Amorós
Journal:  Int Urol Nephrol       Date:  2010-10-08       Impact factor: 2.370

3.  Mixed Bartter-Gitelman syndrome: an inbred family with a heterogeneous phenotype expression of a novel variant in the CLCNKB gene.

Authors:  Amar Al-Shibli; Madinah Yusuf; Issam Abounajab; Patrick J Willems
Journal:  Springerplus       Date:  2014-02-18

Review 4.  Clinical and genetic approach to renal hypomagnesemia.

Authors:  Min-Hua Tseng; Martin Konrad; Jhao-Jhuang Ding; Shih-Hua Lin
Journal:  Biomed J       Date:  2021-11-10       Impact factor: 7.892

5.  Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome.

Authors:  Alejandro García Castaño; Gustavo Pérez de Nanclares; Leire Madariaga; Mireia Aguirre; Álvaro Madrid; Sara Chocrón; Inmaculada Nadal; Mercedes Navarro; Elena Lucas; Julia Fijo; Mar Espino; Zilac Espitaletta; Víctor García Nieto; David Barajas de Frutos; Reyner Loza; Guillem Pintos; Luis Castaño; Gema Ariceta
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

6.  Splicing Characterization of CLCNKB Variants in Four Patients With Type III Bartter Syndrome.

Authors:  Chunli Wang; Yuan Han; Jiaran Zhou; Bixia Zheng; Wei Zhou; Huaying Bao; Zhanjun Jia; Aihua Zhang; Songming Huang; Guixia Ding; Fei Zhao
Journal:  Front Genet       Date:  2020-02-21       Impact factor: 4.599

7.  Historical and geographical distribution of the founder mutation c.610G>A; p.Ala204Thr in the CLCNKB gene linked to Bartter syndrome type III in Spain.

Authors:  Ramón Peces; Rocío Mena; Carlos Peces; Pilar Barruz; Hernando Trujillo; Agustín Carreño; Laura Espinosa; Rafael Selgas; Pablo Lapunzina; Julián Nevado
Journal:  Clin Kidney J       Date:  2021-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.